[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100154063":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":43,"centralContacts":35,"locations":48,"responsibleParty":61,"collaborators":35,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":35,"acronym":35,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":35,"enrollmentInfo":72,"targetDuration":35,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":35,"overallStatus":81,"whyStopped":35,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Bausch & Lomb Incorporated","INDUSTRY",[8,14,19,24],{"label":9,"type":10,"description":11,"interventionNames":12},"2% Twice a day","EXPERIMENTAL","Bepotastine Besilate Nasal Spray 2% Twice a day",[13],"Drug: Bepotastine Besilate Nasal Spray 2% Twice a day",{"label":15,"type":10,"description":16,"interventionNames":17},"3% Twice a day","Bepotastine Besilate Nasal Spray 3% Twice a day",[18],"Drug: Bepotastine Besilate Nasal Spray 3% Twice a day",{"label":20,"type":10,"description":21,"interventionNames":22},"4% Twice a day","Bepotastine Besilate Nasal Spray 4% Twice a day",[23],"Drug: Bepotastine Besilate Nasal Spray 4% Twice a day",{"label":25,"type":26,"description":27,"interventionNames":28},"Placebo","PLACEBO_COMPARATOR","Placebo nasal spray",[29],"Drug: Placebo Nasal Spray",[31,36,38,40],{"type":32,"name":11,"description":33,"armGroupLabels":34,"otherNames":35},"DRUG","nasal spray",[9],null,{"type":32,"name":16,"description":33,"armGroupLabels":37,"otherNames":35},[15],{"type":32,"name":21,"description":33,"armGroupLabels":39,"otherNames":35},[20],{"type":32,"name":41,"description":33,"armGroupLabels":42,"otherNames":35},"Placebo Nasal Spray",[25],[44],{"name":45,"affiliation":46,"role":47},"Tim McNamara, PharmD","ISTA Pharmaceuticals, Inc.","STUDY_DIRECTOR",[49],{"facility":46,"status":35,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":35},"Irvine","California","92618","United States","US",{"type":56,"coordinates":57},"Point",[58,59],-117.82311,33.66946,{"lat":59,"lon":58},{"type":62,"investigatorFullName":35,"investigatorTitle":35,"investigatorAffiliation":35,"oldNameTitle":35,"oldOrganization":35},"SPONSOR","100154063","phase-2-safety-and-efficacy-of-bepotastine-besilate-nasal-spray-in-the-treatment-of-seasonal-allergic-rhinitis-100154063",true,"NCT01277341","Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis","Inclusion Criteria:\n\n* Male or female at least 12 years of age with a history of mountain cedar allergy\n\nExclusion Criteria:\n\n* No active nasal infection or nasal abnormality that would affect subject safety or symptom assessments",false,"ALL","12 Years",{"count":73,"type":74},601,"ACTUAL","INTERVENTIONAL",[77],"PHASE2","This is an efficacy study of bepotastine besilate nasal spray in seasonal allergic rhinitis.",[80],"Seasonal Allergic Rhinitis","COMPLETED","2020-10-01",{"date":84,"type":74},"2020-10-05",{"date":86,"type":35},"2010-12",{"date":88,"type":74},"2011-05",{"name":5,"class":6},1]